Cabaletta Bio (CABA) Payables (2018 - 2025)

Cabaletta Bio has reported Payables for 8 years, with the latest figure at $6.6 million in Q4 2025.

• For the quarter ending Q4 2025, Payables rose 34.8% year-over-year to $6.6 million; the trailing twelve-month figure through Dec 2025 stood at $6.6 million (up 34.8% YoY), and the FY2025 full-year result was $6.6 million, up 34.8% from the prior year.
• Payables for Q4 2025 stood at $6.6 million, down from $8.3 million in the prior quarter.
• The five-year high for Payables was $8.3 million in Q3 2025, with the low at $1.3 million in Q1 2021.
• Average Payables over 5 years is $3.9 million, with a median of $3.8 million recorded in 2022.
• Year-over-year, Payables tumbled 39.78% in 2024 and surged 279.22% in 2025.
• Tracing CABA's Payables over 5 years: stood at $2.3 million in 2021, then gained by 5.57% to $2.5 million in 2022, then soared by 84.61% to $4.5 million in 2023, then grew by 8.27% to $4.9 million in 2024, then soared by 34.8% to $6.6 million in 2025.
• The last three Payables figures came in at $6.6 million (Q4 2025), $8.3 million (Q3 2025), and $7.2 million (Q2 2025), per Business Quant data.

Peer Comparison